We examined the role of Toll-like receptors (TLRs) by using TLR2-deficient (TLR2 
mune system are germ line-encoded pattern-recognition receptors, such as Toll-like receptors (TLRs) [3] . The TLR family interacts with conserved pathogenassociated molecular patterns (PAMPs) that are characteristic of and specific to groups of microbial species. Mammalian TLRs-homologues of Drosophila Tollare type 1 transmembrane proteins characterized by extracellular leucine-rich repeats and an intracellular TLR/interleukin (IL)-1 receptor/plant resistance domain [4] . Challenge of microbial products through TLRs activates signal transduction pathways that induce the subsequent inflammatory response [5] . A broad spectrum of PAMPs has been implicated and is recognized by a limited number of TLRs. For example, peptidoglycan (PGN) from gram-positive bacteria is recognized by TLR2, bacterial lipopolysaccharide (LPS) is recognized by TLR4, and bacterial cytosine-phosphodiester-guanine DNA is recognized by TLR9 [6] . Furthermore, TLR2 and TLR4 mediate recognition of a large variety of PAMPs, due to both formation of homomeric TLR complexes or heterodimerization with TLR1 and TLR6, respectively [7] . Other researchers recently have reported the involvement of TLR2 and TLR4 in the recognition of various microbial structures [8] [9] [10] .
Ever since the description of Drosophila Toll as a signal transducer in antifungal response, mycological research has focused on molecular mechanisms of cellular fungi recognition and on fungal PAMPs that are structural components of the cell wall. The cell wall of C. albicans is composed mainly of chitin, mannan, mannoproteins, glucans, and glycolipids [11] . TLR2 and TLR4 have been implicated in recognition of Aspergillus fumigatus, and TLR4 has been implicated in sensing glucuronoxylomannan of Cryptococcus neoformans [12] . TLR2/TLR6 heterodimers are important in cellular recognition of yeast zymosan, a lysate of Saccharomyces cerevisiae [7] , whereas S. cerevisiae-derived mannan is detected by TLR4 [13] . TLR signaling activates the transcription factors NF-kB and/or c-Jun/activator protein (AP)-1, which activate genes of inflammatory cytokines involved in the innate and adaptive immunity. They play crucial roles in the immune response toward microbial challenges, such as candidiasis [14] [15] [16] [17] .
In the present study, we identified the TLRs responsible for recognition of 2 C. albicans preparations: viable and AM-treated C. albicans. We found that both TLR2 and TLR4 are involved in recognition of viable wild-type (wt) C. albicans strains, whereas C. albicans treated with a mixture of 3 antifungal drugs (amphotericin B, nystatin, and itraconazole) use mainly TLR2 in murine macrophages and transfected human embryonic kidney (HEK) 293 cells. Moreover, we show that C. albicans induces activation of signal transduction cascades involving IkBa and the mitogen-activated protein (MAP) kinases p38, c-Jun NH 2 -terminal kinase (JNK), extracellular-related kinase (ERK), and c-Jun/AP-1.
MATERIALS AND METHODS

Reagents and Antibodies
All reagents were purchased from Sigma, unless stated otherwise. Oligonucleotide ODN1668 (TCCATGACGTTCCTGAT-GTC) was commercially synthesized by TIB MOLBIOL (Berlin, Germany) in a phosphothioate-protected form. If not stated otherwise, materials required for cell culture were obtained from Invitrogen. All control and phosphospecific antibodies used were obtained from New England Biolabs, except for bactin (Sigma).
Candida Strains
Preparations of wt strains. The clinical (viable) wt C. albicans strain SC5314 was used in the present study [18] . For fungal challenge of murine macrophages and transfected human cells, inocula were prepared by culturing C. albicans for 24 h at 37ЊC on Sabouraud-dextrose agar (Difco Laboratories). Viable cells were washed 3 times in 0.9% NaCl, and cells were then 5 2 ϫ 10 suspended in 10 mL of YPD medium (1% yeast extract, 2% peptone, and 2% dextrose; Difco). The suspension was cultured for 16 h at 25ЊC through orbital shaking, followed by shaking in fresh medium for a further 24 h at 37ЊC. After washing 3 times with sterile PBS, the final inoculum was then adjusted to the desired density with sterile PBS solution. Dilutions containing 10 0 -10 9 cells/100 mL were prepared for stimulation of murine macrophages.
AM-treated preparations. A mixture of the AMs amphotericin B (4.5 mg/mL), nystatin (4.5 mg/mL), and itraconazole (3.0 mg/mL) was dissolved in dimethylsulfoxide. Viable wt dilutions (10 0 -10 9 cells/100 mL PBS) were coincubated with the AMs for 72 h and then washed 3 times with sterile PBS, to remove the remaining traces of the AMs. After this treatment, viable colonies were not observed on a Sabouraud-dextrose agar plate. All tissue cultures were incubated at 37ЊC with 5% CO 2 at 100% humidity.
Cell Lines and Mice
HEK293 cells (ATCC CRL-1573) were grown in Dulbecco's modified Eagle medium supplemented with 2% heat-inactivated, endotoxin-free fetal calf serum (Roche) and penicillin/ streptomycin. Peritoneal macrophages were cultivated in RPMI 1640 medium supplemented with 10% heat-inactivated, endotoxin-free fetal calf serum, 2 mmol/L l-glutamine, 1% mercaptoethanol, and penicillin-streptomycin. wt and TLR4-defective (TLR4 d/d ) mice were obtained from Charles River Laboratories. TLR2-deficient (TLR2 Ϫ/Ϫ ) mice bearing a targeted disruption of the TLR2 gene [19] were provided by Tularik and were generated by Deltagen (Redwood City, CA strain [9] . Matched mice descending from homozygous breeding pairs of the 4 genotypes were used for experiments.
Genotypic characterization. DNA was isolated from mouse tail-biopsy specimens, according to standard procedures [20] .
NF-kB Reporter Assay
HEK293 cells that were not responsive to numerous PAMPs but that were responsive to IL-1b and tumor necrosis factor (TNF)-a were used for analysis of TLR-dependent cell activation. NF-kB-dependent reporter gene activation was used as read out. HEK293 cells were plated at a concentration of cells/well in a 96-well plate and cotransfected with an 4 3 ϫ 10 NF-kB-dependent endothelial leukocyte adhesion molecule-1 promoter luciferase construct [21] , a Rous sarcoma virus-promoter b-galactosidase reporter plasmid, an MD2 expression plasmid (provided by Dr. Kensuke Miyake, University of Tokyo, Tokyo, Japan; [22] ), and cytomegalovirus (CMV) promoterregulated plasmids for expression of human TLRs (hTLRs), as indicated by the calcium phosphatase precipitation method [23] . DNA plasmids for expression of TLRs were applied as described elsewhere [21] .
Determination of LPS Content
A potential contamination by endotoxin was analyzed by use of a limulus amebocyte lysate-based kinetic assay (QCL-1000; BioWhittaker) in combination with the b-glucan blocker kit (BioWhittaker), according to the specifications of the manufacturer. All samples were spiked with defined amounts of LPS and gave recovery rates of 100%-106%.
Isolation of Macrophages
Peritoneal cells were isolated from 6-10-week-old mice, according to standard procedures. Mice were injected intraperitoneally with 2 mL of 4% thioglycollate. Five days after injection, peritoneal cells were harvested by lavage with sterile PBS. Cells were washed with PBS, counted in a Neubauer chamber, and seeded on culture plates.
Stimulation and Preparation of Protein Extracts
Murine macrophages and HEK293 cells ( cells/well) were 6 1 ϫ 10 plated in each well of a 12-well tissue-culture plate and incubated overnight. Depending on the subsequent experimental procedure, macrophages were cultivated for 18 h in the presence or absence of 50 ng/mL interferon (IFN)-g. After stimulation with the respective Candida preparation, the cells were washed twice in 2 mL of ice-cold sterile PBS, resuspended in 1 mL of icecold sterile PBS, scraped off, and centrifuged for 15 min at 11,000 g at 4ЊC. Thereafter, the pellet was subsequently resuspended in 50 mL of lysis buffer (20 mmol 
, and 1 EDTAfree protease inhibitor cocktail tablet [Roche] ) and incubated on ice with extensive shaking for 30 min. The cell debris was removed by centrifugation for 5 min at 11,000 g at 4ЊC. The protein concentration of the supernatant was determined by spectrophotometric assay (Bio-Rad), according to the manufacturer's instructions.
Western-Blot Analysis
Phosphorylation of IkB-a, the MAP kinases, and c-Jun was evaluated according to the protocol of the manufacturer of the phosphospecific antibody (New England Biolabs). Identity of the bands was confirmed by use of mass molecular markers and positive controls supplied by the manufacturer. b-actin was used as the cell-extract loading control.
Electrophoretic Mobility Shift Assay
A double-stranded oligonucleotide containing a consensus transcription factor binding site for NF-kB (5 -AGTTGAGGG-GACTTTCCCAGGC-3 ) was purchased from Promega and end-labeled with [g-32 P]-dATP by use of T 4 polynucleotide kinase (New England Biolabs) at 37ЊC for 30 min. The nuclear extracts (5 mg) were then incubated with 1 mg/mL poly(dI-dC) and a 32 P-labeled DNA probe in a binding buffer (100 mmol/ L KCl, 30 mmol/L HEPES, 0.3 mmol/L EDTA, 10% glycerol, 1 mmol/L DTT, 1 mmol/L PMSF, 1 mg/mL aprotinin, and 1 mg/mL leupeptin) for 25 min at room temperature. The protein-DNA complexes were subsequently resolved on a 4% PAGE (40:1) gel in 0.5ϫ Tris-borate-EDTA buffer. After electrophoresis, the gels were dried on chromatography paper (Whatman 3M) and exposed to films for audiography.
Determination of TNF-a Concentration
Peritoneal exudate macrophages were seeded at a concentration of cells/well in a 96-well plate. After 2 h, plates were 5 1.5 ϫ 10 washed, to remove nonadherent cells. Plates were pretreated with 10 U/mL IFN-g for 18 h. Subsequently, cells were challenged with viable C. albicans ( cells/well). Supernatants were 7 1 ϫ 10 harvested after 48 h, and TNF-a concentrations were determined by use of a commercially available ELISA (R&D Systems).
RESULTS
Activation of NF-kB in murine macrophages by C. albicans.
We studied the effect of different concentrations of C. albicans on the DNA-binding activity of NF-kB. Macrophages isolated from wt mice were stimulated with increasing concentrations, from 10 0 to 10 7 viable (figure 1A) or AM-treated (figure 1B) C. albicans organisms/100 mL of PBS, respectively. Cells were analyzed after 0.5, 1, 2, 3, and 5 h. Viable C. albicans and AMtreated C. albicans induced strong activation of NF-kB, whereas the respective unstimulated controls failed to induce NF-kB. Although activation of NF-kB after treatment with viable C. albicans had reached its maximum at a concentration of 10 6 cells/100 mL of PBS after 1 h, stimulation with AM-treated C. albicans peaked at a concentration of 10 7 cells/100 mL of PBS after the same time. In both preparations, induction of NF-kB declined after 2 h, whereas no induction could be detected after 3 and 5 h (data not shown). Activation of NF-kB was preceded by phosphorylation and degradation of its inhibitor, IkB-a (figure 1C) . PMA (50 ng/mL) was used as the positive control; negative controls (Co) included nuclear extracts from unstimulated macrophages and extracts from macrophages treated with the AM agents amphotericin B (4.5 mg/mL), nystatin (4.5 mg/mL), and itraconazole (3.0 mg/mL). Nuclear extracts were incubated with a 32 P-labeled NF-kB probe and analyzed by electrophoretic mobility shift assay. Arrows, The complex of g- Although NF-kB promoter activation of HEK293 cells expressing TLR2 was very weak, strong activation was observed after stimulation with AM-treated C. albicans, compared with the respective unstimulated controls and vectors. TLR4 was involved only in the recognition of AM-treated C. albicans. After challenge with increasing amounts of AM-treated C. albicans, activation of reporter genes in HEK293 cells was dose dependent with respect to both TLR2-and TLR4-mediated cell activation (figure 2B). To rule out the possibility that the observed TLR-dependent activations were due to contamination with endotoxin, we determined the LPS concentration in the fungal preparations by use of a limulus amebocyte lysate-based kinetic assay in the presence of a b-glucan blocker. Only trace amounts of endotoxin activity (!2 pg/mL) were detectable in the preparations. Similarly, preincubation with polymyxin B blocked LPS-triggered translocation of NFkB in macrophages, whereas activation triggered by C. albicans was not affected, when LPS was excluded as a contaminant (data not shown).
Involvement of TLR2 and TLR4 in C. albicans-induced activation of NF-kB in peritoneal macrophages. Peritoneal macrophages were first cultivated for 18 h in the presence or absence of 50 ng/mL IFN-g and subsequently stimulated by the addition of viable and AM-treated C. albicans for 1 h. As shown in figure 3 , NF-kB binding was observed in wt macrophages independent of pretreatment with IFN-g. However, after stimulation with viable C. albicans, no NF-kB DNA binding could be detected in TLR2 macrophages showed a clear activation of NF-kB independent of preincubation with IFN-g ( figure 3B ).
Release of TNF-a from peritoneal macrophages after challenge with viable C. albicans. Peritoneal macrophages were first cultivated in the presence or absence of IFN-g (10 U/mL) for 18 h and subsequently stimulated by addition of viable C. albicans (10 7 cells/100 mL PBS). After incubation for 48 h in total, supernatants were harvested, and concentrations of TNF-
Figure 2. Activation of NF-kB in human embryonic kidney 293 cells transfected with human (h) Toll-like receptor (TLR) 2 and hTLR4 after stimulation with viable Candida albicans (A) and antimycotic (AM)-treated C. albicans (A and B).
Luciferase activities of cells transiently transfected with genes encoding either hTLR2 or hTLR4. All cells were cotransfected with expression plasmids for hMD2, hCD14, and a luciferase reporter plasmid. Cells were stimulated with the C. albicans preparations indicated (viable and AM treated). Control stimulus was applied at a concentration of 0.1 mg/mL of lipopolysaccharide (LPS) from Escherichia coli 0111:B4. Bars, for 1 of 3 independent experiments in which each transfection was mean ‫ע‬ SE performed in duplicate. a were determined. As shown in figure 4 , very low concentrations of TNF-a were detectable in supernatants of macrophages that were not preincubated with IFN-g, except for wt macrophages. Among macrophages pretreated with IFN-g, wt and TLR4 d/d macrophages released high amounts of TNF-a, whereas secretion of TNF-a was significantly lower in supernatants of TLR2 Ϫ/Ϫ and TLR2 Ϫ/Ϫ /TLR4 d/d macrophages, compared with those from control mice. These results underline the importance of TLR2 for recognition of viable C. albicans and subsequent release of a NF-kB-regulated cytokine by macrophages.
Involvement of p38, ERK, and JNK in the C. albicansinduced response in macrophages. We next analyzed whether challenge of cells with AM-treated C. albicans activated the MAP kinases p38, ERK, and JNK (figure 5). Peritoneal macrophages from wt mice were stimulated with AM-treated C. albicans, at a density of 10 7 cells/100 mL of PBS. After 5 min, 
DISCUSSION
Several receptors expressed by macrophages bind molecules that are components of the C. albicans cell wall. Among these are amannosides bound by the macrophage mannose receptor [24] , b-1,6 glucans bound by the b-glucan receptor [25] , b-1,3 glucans bound by the dectin-1 receptor [26] , and phospholipomannan bound by TLR2 [27] . Previous work has implicated TLR2 and TLR4 in host defense to C. albicans. According to Netea et al. [28] , TLR4 is partially involved in chemokine secretion and is fully involved in neutrophil recruitment, whereas the expression of proinflammatory cytokines, such as TNF-a, is mainly TLR2 dependent. For the present report, we further analyzed aspects of TLR-mediated C. albicans recognition for promotion of an inflammatory response. In particular, we were interested in whether the recognition of viable C. albicans by macrophages differs from recognition of AM-treated C. albicans. Furthermore, we preincubated the macrophages with IFN-g, because this procedure mimics an underlying minor, primary infection that may influence susceptibility to Candida infections [29] . With regard to the preparation of AM-treated C. albicans, we applied a mixture of 3 antifungals (i.e., amphotericin B, nystatin, and itraconazole), because the combination of 2 or 3 classes of antifungals is a common and promising strategy used in clinical practice to combat the antifungal drug resistance and high mortality rates seen in systemic fungal infections, especially if the drugs have different mechanisms of action [30] . To our knowledge, the effect of these AMs against C. albicans with regard to the activation pattern of TLRs and to the signal transduction of c-Jun/AP-1 has not yet been reported in other studies. Viable C. albicans was not recognized by HEK293 cells expressing TLR2 (figure 2A). Because TLR2 is known to dimerize with other molecules involved in pattern recognition, such as TLR1 and TLR6 [31] , we cotransfected TLR2 with TLR1 and TLR2 with TLR6, respectively. Neither cotransfection of TLR2 with TLR1, nor of TLR2 with TLR6, mediated a synergistic effect (data not shown), which suggests that TLR1 and TLR6 might not be involved in C. albicans recognition, as has been shown for PGN [6] . We also did not observe TLR4-dependent activation by viable C. albicans in HEK293 cells overexpressing from experiments mean ‫ע‬ SE performed in duplicate. As a positive control stimulus, the TLR9-specific oligonucleotide ODN1668, representing cytosine-phosphodiester-guanine DNA, was applied at a concentration of 2 mmol/L. ND, not detectable. figure 2A ). On the other hand, stimulation of HEK293 cells with increasing amounts of AM-treated C. albicans pointed toward CMV promoter-driven expression of TLR2 and TLR4, which implies that both receptors are involved in the recognition of AM-treated C. albicans ( figure 2B) .
TLR4 (
Challenge of murine macrophages with Candida preparations revealed different TLR activation patterns (figure 3), compared with HEK293 cells ( figure 2A and 2B) , which may be due to costimulating factors lacking in HEK293 cells or functional differences of murine and human TLRs, as has been shown for TLR4 [32] . However, our side-by-side analysis of human and murine TLR2 revealed no species specificities (data not shown). Using gel-shift analyses, we investigated NF-kB activation in mouse macrophages after challenge with different amounts of viable and AM-treated C. albicans (10 5 -10 9 cells/ 100 mL of PBS; figure 3 ). We demonstrated that macrophages deficient either for TLR2 or functional TLR4 were unresponsive to viable C. albicans ( figure 3A and 3B) , underlining the importance of both receptors which complements the results of Netea et al. [28] that implicated both TLR2 and TLR4 in the recognition of viable C. albicans. Most interesting, pretreatment of macrophages with IFN-g enabled activation of NF-kB ( figure  3A ) and an increased expression of TNF-a in macrophages lacking TLR4 (figure 4), which may be due to up-regulation of TLR2. In this case, TLR4 was not found to be essential for the recognition of viable C. albicans in murine macrophages. Similar results of this cytokine-induced up-regulation of TLRs have been shown in other cells, such as neutrophil granulocytes [33] , oral epithelial cells [34] , and renal epithelial cells [35] . We did not investigate the capacity of AM-treated C. albicans to induce the release of TNF-a, because Candida-induced production of TNF-a is mediated by TLR2 [28] and because we have shown in our own studies that both Candida preparations are recognized through TLR2. Thus, a significant difference in the release of TNF-a was not expected.
With regard to the stimulation of mouse macrophages with AM-treated C. albicans, our results indicate that activation of NF-kB is dependent solely on TLR2 (figure 3B), which seems to be in contrast to the TLR2/TLR4 dependency observed for viable C. albicans. This different TLR activation pattern might be explained by the presence of additional PAMPs in the AM-treated preparation. With regard to the mechanism of action of the applied AMs, itraconazole is a triazole derivate that inhibits the biosynthesis of ergosterol, the major component of the cell wall of fungi, by interfering with fungal cytochrome-p-450-isoenzymes [36] . Amphotericin B and nystatin are polyenes that form a complex with ergosterol because of their amphiphilic structure, which results in disintegration of the cytoplasmic membrane and in the formation of minute pores, which are linked to leakage and cell death [37] . Because of the mode of action of the latter 2 agents, it is tempting to speculate that isolated fungal PAMPs that activate only TLR2 might be liberated from the cell wall or cytoplasm by the destruction of the membrane. A further explanation may be a potential complexation of the membrane, which may lead to alteration of cell-wall structures, thus becoming immunostimulatory in a TLR2-dependent manner. Recently, amphotericin B has been reported to stimulate cells through TLR2, CD14, and the adapter protein MyD88 [38] . This suggests that our AM-treated Candida preparations activated TLR2 after treatment with amphotericin B. However, the lack of NF-kB activation in our negative controls with extracts from macrophages treated solely with the AM agents, including amphotericin B, as well as in macrophages stimulated with dilutions of 10 0 -10 6 AM-treated Candida cells, rule out a potential stimulatory effect of the AM agents at the concentrations applied ( figure 1A and 1B) . Our results imply that treatment of a C. albicans infection with AMs releases otherwise covered PAMPs and results in TLR2-mediated stimulation of macrophages, in addition to the direct effect of these drugs on C. albicans.
Analysis of the signal-transduction pathways involved in the activation of transcription factors that follows recognition of AMtreated C. albicans showed that degradation of NF-kB is preceded by degradation of IkB-a ( figure 1C) , whereas no degradation of IkB-b could be detected (data not shown). This result is in line with IkB-a being the inhibitory subunit responsible for the regulation of stress-induced activation of NF-kB [39] . Members of the MAP kinase superfamily are known to be involved in TLR signaling and in the activation of transcription factors regulating genes whose products are important in inflammatory processes. For example, the activation of the MAP kinase ERK has been shown to be involved in up-regulation of TLR2 and TLR4 [40] . Recently, activation of p38 by viable C. albicans was shown to be important for the induction of cyclooxygenase-2 in HeLa cells [40] . We have also shown that treatment of peritoneal macrophages with AM-treated C. albicans results in the activation of p38, demonstrating a general role for this MAP kinase in C. albicans-induced cell response (figure 5). However, in contrast to Deva et al. [41] , we observed additional phosphorylation of both ERK and JNK and subsequent activation of the transcription factor c-Jun/AP-1, underlining the functional relevance of JNK phosphorylation ( figure 5 ). This different activation pattern may be explained by the different cellular system, because Deva et al. used HeLa cells; by the different experimental design, because they did not use phosphospecific antibodies; and, which may be most notable, by the use of different stimuli, because they used viable C. albicans for their studies. In contrast to the activation of p38 as the only MAP kinase activated by viable C. albicans [41] , our results indicate the simultaneous activation of NF-kB/IkB-a, of the respective MAP kinases, and of c-Jun/ AP-1 and underline the capacity of AM-treated C. albicans to elicit activation of signaling cascades that originally have been shown to be characteristic for immune activation by classic PAMPs, such as LPS or bacterial lipopeptides [6] . Hence, AMtreated C. albicans constitute a producer of PAMPs that may use the full spectrum of signaling cascades after disintegration and leakage induced by antifungal drugs.
In summary, using cells transfected for expression of distinct human TLRs and TLR-deficient murine macrophages, we have presented evidence that TLR2, but none of the other 10 known TLRs, is involved in recognition of AM-treated C. albicans. Our results indicate that TLR4-dependent cell activation after stimulation with AM-treated C. albicans in human epithelial cells is dose dependent, whereas AM-treated C. albicans was sensed through TLR2 in mouse macrophages in a TLR4-and an IFNg-independent manner. TLR2/TLR4-dependent signaling pathways are essential for the release of NF-kB in mouse macrophages after infection with viable C. albicans cells. In both human and murine cells, pretreatment with IFN-g enhanced TLR2-dependent sensing of viable C. albicans cells in the absence of TLR4. Treatment of C. albicans with cytoplasmic membrane-interacting AM agents induces the activation of NF-kB and underlines the capacity of the TLR system to recognize different cell-wall components. Our work shows that, in addition to NF-kB, cJun/AP-1 is involved in the cellular response to C. albicans. Therefore, our results indicate that viable and AM-treated C. albicans induce host defense through TLRs, NF-kB, and several MAP kinases involved in the signal-transduction pathway, which may contribute to a better understanding of the innate immune recognition of fungal infections.
